Skip to Content

T 150 (Tarceva 150 mg)

Generic Name: erlotinib

Pill with imprint T 150 is White, Round and has been identified as Tarceva 150 mg. It is supplied by Genentech.

Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T 150

Tarceva

Generic Name:
erlotinib
Imprint:
T 150
Strength:
150 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Genentech

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-5447 Physicians Total Care Inc. (repackager)
54569-5848 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide